Drugs Made In America Acquisition Corp. Ordinary Shares
DMAANASDAQ · Financial Services · Shell CompaniesDrugs Made In America Acquisition Corp. operates as a blank check company.
$10.89+0.09%
报价 2026-11-06
市值
$264.4M
EV
$351.3M
PE (TTM)
42.1x
预期 PE
–
52 周区间距高点 0.0%
$10.32$10.89
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| DMAADrugs Made In America Acquisition Corp. Ordinary Shares | $264.4M | +0.1% | – | 0% | 42.1x | – | – | |
| TACOBerto Acquisition Corp. | $393.9M | +0.0% | – | 0% | 61.1x | – | – | |
| ALFCenturion Acquisition Corp. | $388.8M | -0.3% | – | 0% | 33.0x | – | – | |
| TACHTitan Acquisition Corp. | $364.7M | -0.1% | – | 0% | 52.4x | – | – | |
| OYSEOyster Enterprises II Acquisition Corp | $354.1M | -0.1% | – | 0% | 27.8x | – | – | |
| SIMASIM Acquisition Corp. I | $333.3M | -0.9% | – | 0% | 26.7x | 77.4x | – | |
| RTACRenatus Tactical Acquisition Corp I | $326.3M | -0.1% | – | 0% | 59.1x | – | – | |
| 同行中位数 | – | – | – | 0% | 42.7x | 77.4x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。